Glaxosmithkline Holdings (Americas) Inc.

UEI
QQH9KHXNCG81
CAGE
93544
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Entity structure
Other

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$4,222,348

Contract awards

Award Agency Obligated Awarded
Procurement of relenza under hshqdc-10--d-00025 GSK HSHQDC14J00049 Office of Procurement Operations $401,820
Relenza MCM replenishment HSHQDC13J00078 Office of Procurement Operations $819,930
Funding for storage of H5N1 bulk vaccine for 3 6 months of existing doses under contract HHSO100201000071I HHSO10033009T Office of the Assistant Secretary for Preparedness and Response $22,548
GSK storage and stability testing for H5N1 a indo bulk vaccine HHSO10033006T Office of the Assistant Secretary for Preparedness and Response $2,625,700
Vaccine W912L811P0104 West Virginia National Guard (ARNG) $52,232

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Glaxosmithkline Holdings (Americas) Inc. registered in SAM.gov?

Glaxosmithkline Holdings (Americas) Inc.'s SAM.gov registration expired on March 14, 2014.

What is Glaxosmithkline Holdings (Americas) Inc.'s most recent federal award?

Glaxosmithkline Holdings (Americas) Inc.'s most recent federal contract award is Procurement of relenza under hshqdc-10--d-00025 GSK (HSHQDC14J00049), from Office of Procurement Operations, on March 14, 2014.

On GovTribe

See Glaxosmithkline Holdings (Americas) Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login